Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

C.GGC
Sort by: Date|Relevance

Preparing For Toronto: Cannabis LP Executives To Talk About The Canadian Market

It’s that time again. The Benzinga Events team is busy planning for the third Cannabis Capital Conference back in one of our favorite spots and the heart of the cannabis industry—Toronto. The cannabis industry is constantly developing, from market expa...
Hannah Genig | April 1, 2019 |

A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

A psilocybin mushroom, also known as a magic mushroom, offers infinite medical and scientific potential…from cognitive flexibility to potentially addressing clinical depression and eating disorders. There’s a lot we still don’t kn...
Dave Jackson | September 18, 2020 |

Biopharma + Blockchain = A Better Opportunity

Cannabis is an exciting, emerging sector, with enormous growth and investment potential for decades to come. Blockchain is a red-hot tech trend. Its proponents insist that this is revolutionary technology, with virtually limitless potential for future applications. Give...
Stockhouse Editorial | February 8, 2018 |

A New Frontier in Psychedelic Therapeutics

Cybin X Kernel "A New Frontier in Psychedelic Therapeutics" About the partnership: Cybin Corporation ( N.CYBN , Forum ) will leverage Kernel’s Flow to quantify brain activity during psychedelic experiences in re...
Featured Submission | January 11, 2021 |

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

With the warm, sunny backdrop of Miami Beach, the second iteration of the Benzinga Cannabis Capital Conference filled every seat with enthusiastic and proactive investors who are looking for their next deal in a budding landscape. “Every single person in this room is ...
Hannah Genig | April 1, 2019 |

WATCH: Interviews With Some Of The Biggest Execs From The Cannabis Capital Conference

Benzinga’s 2019 Cannabis Capital Conference in Miami gathered some of the most prestigious cannabis executives, service providers, investors and media in the constantly expanding space. More than 700 attendees had exclusive access to company updates, indus...
Hannah Genig | April 1, 2019 |

Buzz on the Bullboards: the HIDDEN Cannabis Market

After 100 years of cannabis Prohibition, perhaps we shouldn’t be surprised that the normalization of cannabis laws in North America (and around the world) has been a slow, uneven process. Even so, cannabis investors will likely be surprised to learn how clumsy ...
Stockhouse Editorial | March 15, 2019 |

Lannett Signs Exclusive U.S. Distribution Deal with Sinotherapeutics; Shares Up 40%

Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil. This morning generic drug maker Lannett Company Inc. (LCI:NYSE.MKT) anno...
Streetwise Reports | August 29, 2019 |

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

EpiPen manufacturer Mylan N.V. announced today that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. Mylan Inc. (MYL:NASDAQ) and Pfizer Inc. (PFE:NYSE) today anno...
Streetwise Reports | July 31, 2019 |

Buzz on the Bullboards: Investors Talk Cannabis on “10/17”

In the United States, they have “420”. This pop culture reference was a numerical label for 4:20 pm – a time when (according to this urban legend) a group of California high school students would meet to smoke cannabis. But this is also a symbol of the e...
Stockhouse Editorial | October 18, 2018 |
1 2 3 4 5